Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approachFederica Del Chierico, Lorenza Putignani, Cristiano De Stefanis et al.|Hepatology|2016Cited by 710
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC PatientsIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Journal of Personalized Medicine|2020Cited by 44